Setiptiline is a tetracyclic antidepressant (TeCA) and a noradrenergic and specific serotonergic antidepressant (NaSSA), used for its activity as a norepinephrine reuptake inhibitor, an alpha-2 adrenergic receptor antagonist, a serotonin receptor antagonist at 5-HT2A, 5-HT2C, and/or 5-HT3 subtypes, and an H1 receptor inverse agonist/antihistamine.